ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NYMX Nymox Pharmaceutical Corp

0.20
0.00 (0.0%)
After Hours
Last Updated: 19:00:00
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 0.2003
Ask Price 0.2169
News -
Day High

Low
0.1688

52 Week Range

High
0.7427

Day Low
Company Name Stock Ticker Symbol Market Type
Nymox Pharmaceutical Corp NYMX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.20 19:00:00
Open Price Low Price High Price Close Price Prev Close
0.20 0.20
Trades Volume Avg Volume 52 Week Range
0 0 - 0.1688 - 0.7427
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.20 USD

Nymox Pharmaceutical Corp Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
18.1M 90.52M - 0 -6.58M -0.07 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Nymox Pharmaceutical News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No NYMX Message Board. Create One! See More Posts on NYMX Message Board See More Message Board Posts

Historical NYMX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.400.4170.16880.2533196324,359-0.20-50.0%
1 Year0.59290.74270.16880.3838468116,809-0.3929-66.27%
3 Years2.523.500.16881.25223,892-2.32-92.06%
5 Years1.774.900.16881.70185,380-1.57-88.7%

Nymox Pharmaceutical Description

Nymox Pharmaceutical Corp is a biopharmaceutical company focused on developing its drug candidate, NX-1207, for the treatment of BPH and the treatment of low-grade localized prostate cancer.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com